Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce that it has closed the first tranche of its previously announced $20 million ...

Pragmatism’ cannot mean building unconditional trade ties with a Chinese government that engages in widespread human rights violations ...